Skip to main content
logo
Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
2.010
+0.140 (7.49%)
Oct 20, 2026, 4:00 PM EDT - Market closed

Foghorn Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
36.7430.9122.634.1619.231.32
Revenue Growth
51.98%36.75%-33.83%77.63%1357.77%206.74%
Gross Profit
-42.09-54.56-71.93-75.53-86.39-79.01
Operating Income
-68.48-82.11-100.29-107.91-117.14-100.73
Net Income
-64.58-74.28-86.62-98.43-108.88-101.32
Earnings Per Share
-0.97-1.18-1.58-2.34-2.62-2.73
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
167.58158.89243.75234.06345.8154.29
Total Debt
43.141.2737.1345.0751.5158.33
Net Cash (Debt)
124.48117.62206.62188.98294.2995.96
Net Cash Growth
-28.85%-43.07%9.33%-35.78%206.69%-7.53%
Net Cash Per Share
1.871.873.764.507.082.58

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-84.24-86.1-100.41-118.11193.61-50.25
Capital Expenditures
-0.05-0.05-0.91-1.22-1.21-3.31
Free Cash Flow
-84.29-86.15-101.31-119.33192.4-53.56
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-114.57%-176.51%--221.15%--
Operating Margin
-186.38%-265.64%-443.70%-315.93%-609.20%-7637.15%
Pretax Margin
-175.78%-240.33%-383.24%-275.80%-566.27%-7681.58%
Profit Margin
-175.78%-240.33%-383.24%-288.17%-566.27%-7681.58%
FCF Margin
-229.43%-278.72%-448.24%-349.38%1000.63%-4060.88%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
P/FCF Ratio
----1.39-
PS Ratio
3.259.8811.617.9713.87643.15